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Objectives" The aim of this study was to assess the reliability of patency rates calculated on basis of data from a standard 
vascular registry. 
Design and setting: Since 1989, all patients undergoing infrainguinaI bypass procedures have been offered a standard 
follow-up programme at 3 month intervals and all data have been recorded prospectively in a vascular egistry. As part of 
a randomised trial on adjuvant medication in femorocrural bypass urgery, 102 patients, operated on between 1990 and 
1992 were independently and simultaneously monitored. This subgroup was examined at 3 and 12 months postoperatively 
and 100% follow-up was obtained. After completion of the trial we calculated the patency and survival rates using life-table 
methods and compared the results based on the vascular registry with those achieved in the clinical trial. 
Results: Comparing the results from the two databases revealed a marked discrepancy between the calculated figures: 
primary (68% in the registry and 52% in the trial) and secondary patency rates (90% vs. 63%), limb survival (97% vs. 
77% as well as patients urvival rates (95% vs. 85%). The differences could be explained by a substantial number of 
patients being lost to follow-up according to the vascular registry database and the fact that these patients turned out to 
have a significantly increased rate of graft thrombosis, limb amputation and death, respectively. 
Conclusions" Life-table statistics may inadvertently become unreliable if a large proportion of patients is lost to follow-up, 
since failure to examine the patient for any reason may be related to the patients health. In addition to the number of 
patients at risk, it is suggested, that life-table plots should be supplemented with information on the number of patients lost 
to follow-up. 
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Introduction 
Vascular registries are used increasingly for quality 
assurance and surgical audit, but also as the basis for 
reporting results. It is now common to see reports 
based mainly on data from these vascular egistries. I-5 
The prospective nature of the data collection in the 
registries improves the quality of data compared to 
retrospective materials, but how reliable are the results 
generated on registry based information? 
Vascular papers frequently report on patency or 
limb survival following some revascularisation proce- 
dure. At the time of analysis, patients are likely to 
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have been observed for varying lengths of time, thus 
not all contributing to the same length of follow-up. 
One could choose to declare follow-up time less than 
the desired length, e.g. 5 years, as missing data, but 
this would lead to exclusion of a substantial part of the 
observed patients. Life-table methods, used since 
1950, circumvent his problem by utilising also the 
information from patients with shorter follow-up 
time. 6-1° By these methods follow-up is limited by the 
occurrence of the event of interest, e.g. graft occlusion, 
or by withdrawal. The term withdrawal  or censoring, 
describes patients with shorter follow-up time, either 
due to recent operation, death in the follow-up period 
or those who are lost to follow-up. The life-table 
calculations are based on the important assumption 
that a withdrawn patient is subjected to the same 
probability of events as patients with maximum 
follow-up time. 8'1~ This assumption may be accepted 
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for patients withdrawn due to death or recent opera- 
tion, as long as they have been followed for as long as 
possible and, for the recent included patients, the 
treatment hasn't changed since the study was initi- 
ated. But for patients who are lost o follow-up this 
assumption may not always be fulfilled. 
Material and Methods 
In 1989 we initiated a vascular egistry, with collection 
of data on all admitted patients, according to sug- 
gested standards. 7 This registry now comprises the 
backbone of a national vascular egistry in Denmark, 
with collection of 65 parameters on preoperative risk 
factors, peri- and postoperative course and follow- 
up. 12 In the same period all patients undergoing 
infrainguinal bypass procedures were offered a stan- 
dard follow-up programme 6 weeks, 3, 6, 9, 12, 4, 26, 
48 and 60 months postoperativel)~ with routine 
recording of data in the vascular egistry. If .patients 
did not attend the follow-up control, they were 
written to once, with an offer of a new appointment. 
Only when not responding to this, were they con- 
sidered lost to follow-up in the registry. 
As part of a randomised study of adjuvant medica- 
tion in femoro-infrapopliteal bypass surgery (Iloprost 
Multicentre Femorocrural Bypass Study), 102 of these 
patients, operated on between October 1990 and June 
1992, were independently and simultaneously mon- 
itored with follow-up at 3 and 12 months. If they did 
not attend the follow-up control and did not respond 
to the offer of a new control additional measures were 
taken to persuade the patient o appear or information 
was collected from general practitioners, local hospi- 
tals, central hospital patient registries etc. By these 
means it was possible to obtain 1 year follow-up 
information from all 102 patients in the study on the 
end points of patenc)~ limb survival and patient 
survival. 
Comparison was made between the data in the trial 
database and in the standard vascular egistry on the 
same group of patients. Differences in distributions 
was determined by the Chi-squared test. Patenc)5 limb 
survival and patient survival were estimated by the 
Kaplan-Meier life-table method. In the interpretation 
of data we separated censored patients into patients 
withdrawn of legitimate causes, e.g. death and recent 
operation, and patients lost to follow-up. In this paper, 
patients were considered lost to follow-up if more 
than 4 months had passed between the last follow-up 
and the time of analysis or death. 
Results 
Primary and secondary patenc)5 limb survival and 
survival were calculated for the registry-based data 
and for the trial-based data. In all instances, the 
Kaplan-Meier rates showed marked differences 
between the two groups: The 1 year primary patency- 
rate was 68% reported by the vascular egistry and 
52% when reported from the trial database (Fig. 1). 
Similar differences were seen for secondary patency 
(90% vs. 63%), Limb survival (Fig. 2, 97% vs. 77%) and 
survival (95% vs. 85%). The discrepancy could be 
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Fig. 1. Comparison ofthe cumulated primary patency between the r gistry data (--) and the trial data (--). 
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Fig. 2. Comparison ofthe cumulated limb survival between the registry data (--) and the trial data (---). 
explained by the fact that a substantial number of 
patients were considered lost to follow-up in the 
vascular egistry, and that the event rate among these 
patients was significantly higher than that of patients 
with complete follow-up (Table 1). For limb survival, 
50 patients were considered lost to follow-up in the 
vascular egistry, and amputation had been performed 
in 20 (40%) patients, as compared to two (4%) of 52 
patients with complete follow-up (p < 0.0005). Similar 
results were obtained for patency and patient survival 
data (Table 1). The modest differences in the number 
of patients at risk at 3, 6, 9 and 12 months, as indicated 
in Figs. 1 and 2, compared to the marked difference in 
patency rate, are also explained by the high event rate 
in the trial data. Although the potential number of 
patients at risk is increased substantially by complete 
follow-up, the high event rate makes the patients 
disappear again. 
Discuss ion  
Reporting results after vascular surgery has constantly 
been an issue of great attention and life-table methods 
were widely adopted for this purpose during the 
seventies and eighties, both in the United States and 
Europe. 7-9 Underwood et al. considered how to 
present he validity of life-table plots and suggested, 
that the graphic presentation should include the 
number of patients at risk. 8 He also considered 
including the number of patients lost to follow-up, but 
concluded that the number at risk would be sufficient, 
as weak data would reveal themselves through this 
parameter alone. In 1986 an Ad Hoc Committee on 
Reporting Standards in the U.S.A. stated that "the life- 
table method is probably the best commonly used way 
of presenting patency data'.  7 It was suggested that 
reports with patency data for each time interval 
should include the number of grafts at risk, the 
number of occluded grafts and number of withdrawn 
patent grafts, subdivided into the withdrawal due to 
short duration, death or loss to follow-up. This 
practice has obtained some support in the U.S.A. but is 
seldomly used in European publications. It is suitable 
when data are presented at intervals, but in recent 
years it has become common to present data in 
Kaplan-Meier plots with a continuous time axis, 
Table 1. The number of events for the patients with complete 1 year follow-up and for the patients who were lost to follow-up in the 
vascular registry 
Complete follow-up Lost o follow-up 
No. Events % No. Events % Chi-squared test p 
Primary patency 64 
Secondary patency 58 
Limb survival 52 
Patient survival 51 
26 41 38 23 61 0.05 
9 16 44 29 66 < 0.0005 
2 4 50 20 40 < 0.0005 
4 8 51 13 26 0.0005 
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which would result in an extensive table correspond- 
ing to the graphical presentation. 
It was unpleasant o discover that our standard 
registry data on peripheral bypass procedures differed 
substantially from the data obtained from a pro- 
spective trial, despite the fact that all patients were 
offered a standard follow-up programme. The reasons 
were that a high proportion of patients were lost to 
follow-up in the vascular egistry and that these did 
not have the same course as that of the patients with 
complete follow-up (Table 1). We believe that these 
observations may reflect a general problem in inter- 
preting data from vascular egistries and that reports 
tend to be too optimistic, if complete or near complete 
follow-up is not obtained. Explicit information on the 
number of patients lost to follow-up is seldomly 
provided in the literature. If any information exists it 
is usually in the form of total number withdrawn. 
Making the assumption that patients lost to follow-up 
have a more unfavourable course than patients with 
complete follow-up, we have estimated the potential 
implications on results presented in two vascular 
papers, in which information was provided on the 
number of patients lost to follow-up. 13'14 In the first 
example, presenting the results after femoropopliteal 
angioplasty the 5 year primary patency rate was 45%, 
and 19% of patients were lost to follow-up. 13 If we 
make the same assumption as in the present series, i.e. 
patients lost to follow-up carry a 20% higher risk of 
thrombosis, the patency would decrease from 45% to 
32% (Fig. 3). Similar calculations can be made, based 
on a study presenting follow-up data on infrainguinal 
in situ bypass procedures, in which the 10-years 
primary patency rate was reported as 59%, but would 
probably be 44%, if the 27% of patients who were lost 
to follow-up behaved like the patients in the present 
series. 14 In both examples a substantial number of 
patients were lost to follow-up during the period of 
observation (19% and 27%, respectively), which had 
significant impact on patency rates under the given 
assumption (Fig. 3). This may in part explain the 
marked differences in reported patency rates between 
otherwise comparable studies: when a high propor- 
tion of patients is lost to follow-up it is possible to 
report good results that are not really based in reality 
without intending to do so. 
This raises the need for a fairly simple method of 
detecting the quality of follow-up data from the 
vascular egistry. In addition to the number of patients 
at risk we suggest that any life-table calculations 
should include the number of patients lost to follow- 
up, presented as a number at a given time interval, or 
better, presented graphically as part of the Kaplan- 
Meier plot (Fig. 4). In both instances, the validity of the 
follow-up can be estimated at a glance. Moreover, it is 
important o define when patients are considered lost 
to follow-up, i.e. the acceptable time interval between 
the last follow-up and the time of analysis or death. 
Increasing the acceptable time interval raises the risk 
that the event monitored for has occurred, but remains 
unregistered. In this paper we considered four months 
as an acceptable interval, but longer intervals may 
well be acceptable in long-term follow-up studies. 
In conclusion, the increasing use of vascular egis- 
tries for reporting results necessitates a simple way of 
stating the validity of follow-up. We recommend, that 
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life-table data should be supplemented with informa- 
tion on the number of patients lost to follow-up, in 
addition to the number at risk, as we have found this 
figure to be of potential importance to the calculated 
results from our vascular egistry. If follow-up is not 
complete, results tend to be too optimistic. 
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